🇺🇸 FDA

Drug profile · INN

pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)

FOCLIVIA

J07BB02
Patents linked
0
News articles
0

Quick answer

pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) (FOCLIVIA) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)
Brand FOCLIVIA
ATC code J07BB02

Frequently asked questions

What is pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)?

pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) (FOCLIVIA) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)?

FOCLIVIA is a marketed brand name for pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted). Check FDA Drugs@FDA for the current US label holder and prescribing information.